Search Results

CSL focuses on product research and development to ensure we are well positioned to deliver new and improved therapies for unmet patient needs.

https://corporateresponsibility.csl.com/innovation

In Australia, CSL contributes to a range of public policy debates in which we have expertise including biopharmaceuticals, medical research, patient advocacy and more.

https://corporateresponsibility.csl.com/marketplace/public-policy/australian-initiatives

CSL regards stakeholder engagement as a foundation of corporate responsibility, and have identified our key stakeholders as patient groups, employees, investors, regulators, suppliers, government, healthcare professionals, plasma donors, business partners and the academic and scientific community.

https://corporateresponsibility.csl.com/approach/stakeholder-engagement

CSL Limited's support for the UN Sustainable Development (SD) Goals

https://corporateresponsibility.csl.com/approach/support-for-the-un-sustainable-development-goals

At CSL, Corporate Responsibility is about conducting our business ethically and contributing to the economic, social and environmental well-being of our communities.

https://corporateresponsibility.csl.com/

CSL’s Global CR Committee has overall responsibility for the materiality process and executes a global materiality assessment on a biennial basis. In 2017/18, we concluded our third such assessment and followed the Global Reporting Initiative (GRI) standards of sustainability context, materiality, completeness and stakeholder inclusiveness through our process of identification, review and prioritisation. The application and disclosure of our materiality process against the GRI materiality principle definition was externally assured by Ernst & Young.

https://corporateresponsibility.csl.com/approach/material-topics

We achieve value creation through high-quality, focused innovation capabilities, operational excellence and global commercial strength.

https://corporateresponsibility.csl.com/-/media/csl/documents/csl-statement-on-modern-slavery-2021.pdf

Read about CSL's approach to stakeholder engagement and review a summary of our performance in key areas such as innovation, safety and quality, community, and environment.

https://corporateresponsibility.csl.com/approach

Innovation and R&D Research and development (R&D) investment ($) 10, 16, 17, 150

https://corporateresponsibility.csl.com/-/media/corporate-responsibility/documents/csl-final-assurance-statement-2022.pdf

CSL Submission Future of Research Innovation - February 2016

https://corporateresponsibility.csl.com/-/media/corporate-responsibility/documents/public-policy-documents/csl-submission-future-of-research-innovation_february-2016.pdf